AditiDhirMD

Pediatric Hematologic Oncology

Assistant Professor

Dr. Dhir is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Alabama Medical CenterFellowship, Pediatric Hematology/Oncology, 2017 - 2020
Cleveland Clinic FoundationResidency, Pediatrics, 2014 - 2017
Lady Hardinge Medical CollegeClass of 2013

PubMed

Congenital urinary tract anomalies are a variable finding associated with nevoid basal cell carcinoma syndrome.
Isha Harshe, Talia Donenberg, Marie Jeanjean, Jesus Ramirez Castano, Frankie Fann
Journal of Medical Genetics. 2025-02-26
Rarerearrangement in a case of de novo pediatric AML and review of cases.
Mathilde Hainaut, Valishti Pundit, C Federico Moral-Ortega, Julio Barredo, David Crawford
Leukemia & Lymphoma. 2025-01-01
Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Fou...
Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M Loeb
Clinical Cancer Research. 2024-12-02

Lectures

An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

University of Miami Miller School of Medicine Selected for National NF2 Tumor Clinical TrialJune 1st, 2022